Jk. Westwick et al., DIFFERENTIAL REGULATION OF HEPATOCYTE DNA-SYNTHESIS BY CAMP IN-VITRO AND IN-VIVO, American journal of physiology: Gastrointestinal and liver physiology, 34(5), 1996, pp. 780-790
Adenosine 3',5'-cyclic monophosphate (cAMP) prevents epidermal growth
factor (EGF)-induced DNA synthesis in many types of cultured cells, in
cluding hepatocytes, but its effects on cellular proliferation in vivo
are unknown. This study compares the effects of supplemental cAMP on
hepatocyte proliferation induced in vivo by 70% partial hepatectomy (P
H) and in vitro by EGF and determines the effects of cAMP on AP-1, a f
amily of growth-regulatory transcription factors, and the kinase casca
des that normally activate AP-1. Although injection of dibutyryladenos
ine 3',5'-cyclic monophosphate (30 mg/kg ip) at the time of PH increas
ed liver cAMP concentrations at least 100-fold for several hours, it d
id not inhibit hepatic incorporation of [H-3]thymidine or proliferatin
g cell nuclear antigen expression 24 h after PH. cAMP treatment led to
a complete inhibition of extracellular signal-related kinase (ERK) ac
tivity and transiently reduced NH2-terminal Jun nuclear kinase (JNK) a
ctivity after PH but did not decrease the expression of c-jun mRNA or
protein. Consistent with the known cAMP stimulation of jun-B in cultur
ed cells, cAMP treatment increased jun-B mRNA, protein, and DNA bindin
g activity post-PH. Surprisingly, cAMP treatment enhanced Raf kinase a
ctivity after PH in rats. In primary hepatocyte cultures, supplemental
cAMP inhibited JNK and ERK activity, total AP-1 and c-Jun transcripti
onal activities, and DNA synthesis. Thus elevated cAMP inhibited ERK a
nd JNK activity in culture and in vivo and inhibited hepatocyte prolif
eration in culture but not in vivo. This suggests that in vivo mechani
sms compensate for cAMP inhibition of certain growth-related signaling
cascades and emphasizes potential risks of extrapolating from simple
cell culture systems to explain physiology in intact animals.